216 related articles for article (PubMed ID: 26274346)
1. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
[TBL] [Abstract][Full Text] [Related]
2. Impact of hyperglycemia on neuropathological alterations during critical illness.
Sonneville R; den Hertog HM; Güiza F; Gunst J; Derese I; Wouters PJ; Brouland JP; Polito A; Gray F; Chrétien F; Charlier P; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
J Clin Endocrinol Metab; 2012 Jun; 97(6):2113-23. PubMed ID: 22442271
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2012 Jan; 97(1):E59-64. PubMed ID: 22013100
[TBL] [Abstract][Full Text] [Related]
4. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
Langouche L; Mesotten D; Vanhorebeek I
Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
[TBL] [Abstract][Full Text] [Related]
6. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
[TBL] [Abstract][Full Text] [Related]
7. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.
Vanhorebeek I; Ellger B; De Vos R; Boussemaere M; Debaveye Y; Perre SV; Rabbani N; Thornalley PJ; Van den Berghe G
Crit Care Med; 2009 Apr; 37(4):1355-64. PubMed ID: 19242345
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: Comment on "FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival" by Thiessen S.E., et al.
Plomgaard P; Weigert C
J Clin Endocrinol Metab; 2015 Oct; 100(10):L102-3. PubMed ID: 26439155
[No Abstract] [Full Text] [Related]
10. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
11. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemic kidney damage in an animal model of prolonged critical illness.
Vanhorebeek I; Gunst J; Ellger B; Boussemaere M; Lerut E; Debaveye Y; Rabbani N; Thornalley PJ; Schetz M; Van den Berghe G
Kidney Int; 2009 Sep; 76(5):512-20. PubMed ID: 19536085
[TBL] [Abstract][Full Text] [Related]
13. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; Güiza F; Martinet W; Timmermans JP; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2011 Apr; 96(4):E633-45. PubMed ID: 21270330
[TBL] [Abstract][Full Text] [Related]
14. [Glycaemia control in critically ill patients is justified and effective].
Rybka J
Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness.
Mesotten D; Delhanty PJ; Vanderhoydonc F; Hardman KV; Weekers F; Baxter RC; Van Den Berghe G
J Clin Endocrinol Metab; 2002 Dec; 87(12):5516-23. PubMed ID: 12466347
[TBL] [Abstract][Full Text] [Related]
16. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.
Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I
Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242
[TBL] [Abstract][Full Text] [Related]
17. [Hyperglycemia and mortality in critically ill children].
Mikos B; Barkai L
Orv Hetil; 2007 Apr; 148(15):683-8. PubMed ID: 17416576
[TBL] [Abstract][Full Text] [Related]
18. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
[TBL] [Abstract][Full Text] [Related]
19. Intensive insulin therapy for critically ill patients.
Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition.
Yan CL; Huang YB; Chen CY; Huang GS; Yeh MK; Liaw WJ
Acta Anaesthesiol Taiwan; 2013 Jun; 51(2):67-72. PubMed ID: 23968657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
